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dl), Group2 (220>TC>=180), Greup3 (TC<180). Normocholesterolemic patients (G2) 
were randomized to two subgroups 2a and 2b. 10mg of pravastatin was given to the 
patients in G1 and G2a. CAG was performed at baseline(BL), follow-up of 2 and 5 years. 
Coronary artedograms were analyzed by QCA at the Core Laboratory. Intervention or 
CABG related coronary branches were excluded from analysis• Primary endpoint was 
angiographic coronary progression evaluated by mean segment diameter (MSD) and 
minimum obstruction diameter (MOD). Secondary sndpoints were clinical events• 
Results: 188 patients had at least one coronary branch to be evaluated. 1021 segments 
for MSD and 849 segments for MOD were analyzed by QCA (data are shown in the 
table: * p<0.05, ** p<0.01 vs. G2b). Both changes in MSD and MOD in G2a were signifi- 
cantly less than those in G2b. Cardiac events (AMI, cardiac death, PTCA and CABG) 
were 31.3% in G1, 24•1% in G2a, 28.8% in G2b and 20.0% in G3. Conclusion: Five- 
years angiographic study revealed cholesterol-lowering therapy by pravastatin prevented 
progression of coronary atheroscleresis even in normolipidsmic patients with CAD. 
Five-Year Follow-Up QCA Results 
Group TC(mg/dl) MSD MOD 
n BL 5y F/U Change n BL 5y F/U Change 
G1 >=220 505 2.630 2.592 -0.037 434 2.029 1.955 -0.074 
G2a 180-219 199 2.715 2~690 -0.025* 158 2.128 2.091 -0.036** 
G2b 180-219 205 2.679 2.610 -0,069 178 2.090 1.934 -0.156 
G3 <=179 112 2.683 2.627 -0,055 79 2.068 2.015 -0.053 
1130-76 Ef fects  of Lipid-lowering Therapy With AtorvastaUn on 
Endothelial Function and Aortic Pulse Wave Velocity in 
Patients With Hypercholesterolemia 
Hideki Watanabe. Masaaki Kakihana, Kunio Nakagawa, KINU Medical Association 
Hospital, Mitsukaido, Japan,/baraki Prefectural University of Health Sciences, Ami, 
Japan• 
To evaluate effects of atorvastatin and vitamin E on endothelial function and aortic stiff- 
ness, thirty-six patients with untreated hypereholastarolemia (total cholesterol>220 mg/ 
dL) were randomized to receive atorvastatin (10mg/day, A group, n=12), vitamin E 
(6001U/day, E group, n=12) or placebo (P group, n=12). By using ultrasound system with 
a 7.5-MHz transducer, the brachial artery diameter was measured at rest and during 
reactive hyperemia, and then before and after 0.3 mg of sublingual nitroglycerin (NTG). 
We measured plasma TBARS (thiobarbitudc acid reactive substances) to evaluate oxi- 
dative stress, and also measured aortic PWV (pulse wave velocity) by using a non-inva- 
sive technique to evaluate aortic stiffness• Measurements were performed at baseline 
and at 4 and 8 weeks after the treatments. At baseline, there was no difference in lipid 
parameters, TBARS (nmot/mL), flow-mediated dilatation (FMD, %increase in diameter 
during hyperemia), NTG-induced dilatation (NID, %increase in diameter after NTG), and 
PWV among three groups. Total cholesterol level was decreased in the A group (4 
weeks: -19%; 8 weeks: -26%), and TBARS was decreased in the E group after 4 and 8 
weeks (Baseline: 2.4±0.7, 4 weeks: 1.9±0.6, 8 weeks: 1.6±0.6). FMD was increased in 
the A and E groups after 4 and 8 weeks. PWV was decreased in the A group after 8 
weeks• NID did not change during the study• Conclusion: Lipid-lowering therapy with 
atorvastatin restores endothelial function and PWV in patients with hypercholester- 
olemia. 
Baseline 4 weeks 8 weeks 
FMD Aton, astatin 3.2 • 1 .O 7.9 • 2_0~1" 9.3 • 1 .~el" 
(%) Vitamin E 3.2 • 0.8 5.2 • 1 .Tt 5.3 • 1 _7t 
Placebo 3.2 • 0.6 3.3 • 1.2 3A • 1.2 
NID Aton, astatin 18.3 • 1.5 17.8 • 2.4 17 .9 ,  1.3 
(~:) YitaminE 17 .7 ,1 .5  17 .9 ,1 :3  18 .0 ,1 .4  
Placebo 18 .5 ,1_4  18 .0 ,1_6  18 .4 ,2_3  
PWV Atorvastatin 1803,116  1738 • 117 1427 ± gs~t 
(cmlsec) Vitamin E 1836 • 118 1823 • 115 175g,  104 
Placebo 1815 • 118 1810 • 138 1806,125  
Mean , SD, w'p<O.Ol vs vitamin E, 1"p<0.01 vs placebo 
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1131-77 The Prognostic Value of Ambulatory Blood Pressure in 
Treated Hypertension: The Office Versus Ambulatory 
(OVA) Blood Pressure Study 
Denis L. Clement, Marc De Buvzere, Dirk De Bacquer, Peter De Leeuw, Daniel A. 
Dupraz, Robert Fagard, Peter Gheeraert, Eoin O'Brien, for the OvA Investigators, 
University Hospital, Ghent, Belgium. 
Background. Prognostic value of ambulatory blood pressure recordings (ABP) in arterial 
hypertension has been studied in several large-scale event-based cohort studies mostly 
with ABP recordings made in untreated or placebo-treated subjects. The Office versus 
Ambulatory (OVA) European multicentre BP study examined whether ABP predicts car- 
diovascular (CV) events and mortality over and above office blood pressure (OBP) in 
treated hypertensive patients ( ABP recordings at > 3 months treatment). Methods. We 
followed 1963 eligible patients (median follow-up 5 years)• There were 157 patients with 
a well-documented validated first new CV event since enrolment. Total mortality com- 
prised 78 cases• Results. Cases (n = 157) were older, had higher total cholesterol and 
triglycerides, had more diabetes and more previous CV history and comprised more 
men. Office and ambulatory (24-h, day- and night-time) systolic BP were higher in the 
cases. In Cox proportional hazards models adjusted for age, gender, risk factors, previ- 
ous CV history and office BP systolic ABP still had independent significant predictive 
value over and above systolic OBP, while significance for diastolic ABP was not reached: 
systolic 24-h ABP 1.4711.24-1.74], systolic clay-time ABP 1.3911.18-1.65], systolic night- 
time ABP 1.4511.24-1.70] ( hazard ratio for 1 SD BP increase, [95%CI]). Even in 
patients(25%) with systolic OBP < 140 mmHg, subjects with high systolic ABP (particu- 
larly at night) had a higher incidence of all CV events. Further subanalysis largely con- 
firmed our results for CV mortality (n = 38). However in adjusted Cox proportional 
hazards models neither systolic or diastolic ABP could predict total mortality ( n = 78) 
over and above OBP. Conclusion. The OvA study demonstrated that systolic ABP pre- 
dicts CV events over and above systolic OBP; this is not the case for diastolic ABP. ABP 
was not predicting total mortality over and above OBP. The OvA study gives evidence 
that ABP monitoring improves CV risk stratification in treated hypertensive patients• 
1131-78 Patient Knowledge and Awareness of the Importance of 
Elevated Systolic Blood Pressure 
Susan A. Oliveria. Roland S. Chen, Bruce D. McCarthy, Catherine C. Davis, Martha N. 
Hill, Wei/I Medical College of Come//University, New York, New York, Bristol-Myers 
Squibb Pharrnaceutica/ Research Institute, Plainsboro, New Jersey. 
Background; improved recognition of the importance of systolic blood pressure (SBP) 
has been identified as one of the major public health challenges in the prevention and 
treatment of hypertension (HTN). This study assesses HTN knowledge and awareness in 
a hypertensive population, specifically focusing on SBP. 
Methods: We identified patients with HTN (n=2,264) in the pdmary care setting of a large 
Midwestern health system using automated claims data (ICD-9 codes 401.0 through 
401.9). We randomly selected 1,150 patients and report interim results on the initial 683 
completed patient telephone interviews (59% response rate); data collection is ongoing. 
Results: In this population of hypertensive patients, awareness was high, with 90% 
reporting that a healthcare provider had told them that they have HTN or high blood pres- 
sure (HBP); however, 39% of patients did not know their blood pressure (BP) level. Of 
patients who did know their BP, 54% reported levels that were _>140 mm Hg and/or _>90 
mm Hg for SBP and diastolic blood pressure (DBP), respectively• Thirty-seven percent of 
these patients reported elevated systolic levels only (SBP _>140 mm Hg and DBP <90 
mm Hg). Interestingly, only 25% of patients with elevated SBP and/or DBP perceived that 
their BP was high• Eighty-two percent of all patients correctly identified the meaning of 
HTN as "high blood pressure." Thirty-two percent of patients correctly identified SBP as 
the "top" number of their reading; 29% correctly identified DBP as the "bottom" number; 
and, overall, only 27% of the patients were able to correctly identify both systolic and 
diastolic BP measures• Twenty-six percent and 24% did not know the optimal level for 
SBP and DBP, respectively. When asked whether the DBP or SBP level was more impor- 
tant in the control and prevention of disease, 43% reported DBP, 14% reported SBP, 28% 
reported that both were important, and 14% did not know. 
Conclusions: These results suggest that although awareness of HTN is high, patients 
do not understand the importance of elevated SBP levels nor the current status of their 
BP control• An opportunity exists to focus patient education programs and interventions 
on the cardiovascular risk associated with elevated SBP levels• 
1131-79 A Compar i son  of  Pressure and Time Characteristics 
Between Aortic and Radial Blood Pressure Waveforms 
Sarah A. Hoee, lan "1. Meredith, James D. Cameron, Monash Medical Centre, Monash 
University, Me/bourne, Australia, La Trobe Universi~ Me/bourne, Australia• 
Background. It is well known that the shape of blood pressure waveforms varies over the 
arterial system• Differences in pressure wave shape and associated descdptive parame- 
ters between brachio-r'edial nd proximal aortic sites are of interest due to suggestions that 
central blood pressure may be a more appropriate clinical indicator than traditional blood 
pressure assessment. 
Methods. Simultaneous invasive ascending aortic (6 or 7Fr coronary catheter) and radial 
artery (applanation tonometry, Millar~ Mikro-tip~ catheter pressure transducer) pressure 
waveforms were recorded using Chart for Powertab, sampling at 200Hz in 98 subjects 
(76male:22female) undergoing elective coronary procedures• Radial waveforms were 
scaled to aortic mean and diastolic pressures by linear interpolation• Parameters for com- 
parison included systolic blood pressure (SBP), augmentation index (AI), diastolic lad) and 
systolic (As) pressure integrals and times to peak pressure (Tp) and to dichrotic notch (Ts). 
Results. Results are expressed comparing radial with aortic sites. Scaled radial SBP was 
closely and linearly related to measured aortic SBP (y=0.9098x + 24.22; p<0.001, r2=0.77) 
with an average difference over the physiological BP range of 12mmHg. Ad and As mea- 
sured at the two sites were also closely associated (r2=0.93 and 0.84raspectively; both 
p<0.00t), as were Tp and Ts (r2=0.2, 0.6; both p<0.001). Although achieving conventional 
significance the association between radial and aortic AI was, as expected, weak (=2--0.04, 
p<0.05). Regression slopes for SBP, Ts, Ad and As did not differ significantly from 1. 
Conclusions• Despite substantial differences in shape between radial and aortic BP wave- 
forms, with close linear relationships and regression slopes of 1, many time, pressure and 
pressure time integral parameters of the central aortic pressure waveform may be deduced 
simply from peripheral waveform data without the need for complex transformation of data• 
Our data suggest that blood pressure ranking, and cardiovascular isk, will be unchanged 
based on either central or peripheral SBP and thus derivation of central aortic waveforms 
may not improve upon conventionally available blood pressure data. 
